Thoratec Corp. will make its first push into the short-term percutaneous coronary intervention circulatory support market as it performs a roll-out of its HeartMate PHP (Percutaneous Heart Pump) device in select European markets during the next two years.
While Thoratec is a leader in the left-ventricular assist device space for heart failure patients on the transplant list or...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?